Gary Park

1.2k citations

31 papers · 880 · h-index 14

Impact in

Hematology top 5%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 14
- Blood Coagulation and Thrombosis Mechanisms 10
Molecular Biology 8
- S100 Proteins and Annexins 2
- Metabolism, Diabetes, and Cancer 2

Co-authors: Muhammad Baluom (3 shared papers)Rajinder Singh (4 shared papers)Elliott B. Grossbard (2 shared papers)Vanessa Taylor (9 shared papers)Esteban S. Masuda (9 shared papers)Ellen Herlaar (2 shared papers)Donald G. Payan (7 shared papers)Sylvia Braselmann (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Transplantation (4 papers)ACS Medicinal Chemistry Letters (2 papers)Cancer Research (2 papers)Drug Metabolism and Disposition (1 paper)
Partner nations: United States Germany Japan

In The Last Decade

Gary Park

30 papers receiving 838 citations

Peers

Countries citing papers authored by Gary Park

Since Specialization

Citations

This map shows the geographic impact of Gary Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Park more than expected).

Fields of papers citing papers by Gary Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Park. The network helps show where Gary Park may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Park Line = papers co-authored together Gary Park links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation Journal of Pharmacology and Experimental Therapeutics ·Sylvia Braselmann, Vanessa Taylor, H. Zhao, Su Wang, Catherine Sylvain, Muhammad Baluom, Kunbin Qu, Ellen Herlaar, Angela Lau, (unknown), Brian Wong, Scott Lovell, Thomas Sun, Gary Park, Ankush B. Argade, Stipo Jurčević, Polly Pine, Rajinder Singh, Elliott B. Grossbard, Donald G. Payan, Esteban S. Masuda	2006	430
2	Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation Drug Metabolism and Disposition ·David J. Sweeny, Weiqun Li, Jeffrey Clough, Somasekhar Bhamidipati, Rajinder Singh, Gary Park, Muhammad Baluom, Elliott B. Grossbard, David Lau	2010	80
3	The occurrence of the anti-cancer diterpene taxol in Podocarpus gracilior Pilger (Podocarpaceae) Biochemical Systematics and Ecology ·Roy W. Stahlhut, Gary Park, Raymond L. Petersen, Wenwen Ma, Peter J. Hylands	1999	39
4	The Deintensification of Terraced Agricultural Land Near Trevelez, Sierra Nevada, Spain Global Ecology and Biogeography Letters ·Terry D. Douglas, Dick Critchley, Gary Park	1996	32
5	Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification Bioorganic & Medicinal Chemistry Letters ·Yonghong Song, Lane A. Clizbe, C. BHAKTA, Willy Teng, Wenhao Li, Paul Wong, Brian Huang, Uma Sinha, Gary Park, Andrea Reed, Robert M. Scarborough, Bing‐Yan Zhu	2002	30
6	Novel Immunosuppression Transplantation ·T. Deuse, Jeffrey B. Velotta, Grant Hoyt, Johannes A. Govaert, Vanessa Taylor, Esteban S. Masuda, Ellen Herlaar, Gary Park, D. C. Carroll, Marc Pelletier, Robert C. Robbins, Sonja Schrepfer	2008	29
7	Design and synthesis of factor Xa inhibitors and their prodrugs Bioorganic & Medicinal Chemistry Letters ·Yonghong Song, Lane A. Clizbe, C. BHAKTA, Willy Teng, Paul Wong, Brian Huang, Katherine Tran, Uma Sinha, Gary Park, Andrea Reed, Robert M. Scarborough, Bing Zhu	2003	24
8	Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs Bioorganic & Medicinal Chemistry Letters ·Penglie Zhang, Liang Bao, Jingmei F Zuckett, Erick A. Goldman, Zhaozhong J. Jia, Ann Arfsten, Susan Edwards, Uma Sinha, Athiwat Hutchaleelaha, Gary Park, Joseph L. Lambing, Stanley J. Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu	2004	21
9	Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Wenrong Huang, Penglie Zhang, Jingmei F Zuckett, Lingyan Wang, John Woolfrey, Yonghong Song, Zhaozhong J. Jia, Lane A. Clizbe, Ting Su, Katherine Tran, Brian Huang, Paul Wong, Uma Sinha, Gary Park, Andrea Reed, J Malinowski, Stanley J. Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu	2003	19
10	Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 structure–activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides Bioorganic & Medicinal Chemistry Letters ·Zhaozhong J. Jia, Yanhong Wu, Wenrong Huang, Erick A. Goldman, Penglie Zhang, John Woolfrey, Paul Wong, Brian Huang, Uma Sinha, Gary Park, Andrea Reed, Robert M. Scarborough, Bing‐Yan Zhu	2002	18
11	Significant Reduction of Acute Cardiac Allograft Rejection by Selective Janus Kinase-1/3 Inhibition Using R507 and R545 Transplantation ·T. Deuse, Xiaoqin Hua, Vanessa Taylor, Mandy Stubbendorff, Muhammad Baluom, Yan Chen, Gary Park, Joachim Velden, Thomas Streichert, Hermann Reichenspurner, Robert C. Robbins, Sonja Schrepfer	2012	18
12	Tetrazolone as an acid bioisostere: application to marketed drugs containing a carboxylic acid Organic & Biomolecular Chemistry ·Matthew A. J. Duncton, Ryan B. Murray, Gary Park, Rajinder Singh	2016	17
13	A Novel JAK3 Inhibitor, R348, Attenuates Chronic Airway Allograft Rejection Transplantation ·Jeffrey B. Velotta, T. Deuse, Munif Haddad, Esteban S. Masuda, Gary Park, D. C. Carroll, Vanessa Taylor, Robert C. Robbins, Sonja Schrepfer	2009	14
14	Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes Bioorganic & Medicinal Chemistry Letters ·Mukund M. Mehrotra, Julie A. Heath, Jack W. Rose, Mark S. Smyth, J. Seroogy, Deborah L. Volkots, Gerd Rühter, Theo Schotten, Lisa Alaimo, Gary Park, Anjali Pandey, Robert M. Scarborough	2002	14
15	Taxoid side‐chain structure determination by electrospray ionization tandem mass spectrometry Rapid Communications in Mass Spectrometry ·Francis Bitsch, Cedric Shackleton, Wenwen Ma, Gary Park, Matthew Nieder	1993	12
16	Inhibition of Purified Factor Xa Amidolytic Activity May Not Be Predictive of Inhibition of In Vivo Thrombosis Arteriosclerosis Thrombosis and Vascular Biology ·Uma Sinha, Pei Lin, Susan Edwards, Paul Wong, Bing‐Yan Zhu, Robert M. Scarborough, Ting Su, Zhaozhong J. Jia, Yonghong Song, Penglie Zhang, Lane A. Clizbe, Gary Park, Andrea Reed, Stanley J. Hollenbach, J Malinowski, Ann Arfsten	2003	12
17	Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Penglie Zhang, Jingmei F Zuckett, John Woolfrey, Katherine Tran, Brian Huang, Paul Wong, Uma Sinha, Gary Park, Andrea Reed, J Malinowski, Stan Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu	2002	11
18	Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Ting Su, Yanhong Wu, Brandon Doughan, Kim Kane‐Maguire, Charles K. Marlowe, James Kanter, John Woolfrey, Brian Huang, Paul Wong, Uma Sinha, Gary Park, J Malinowski, Stan Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu	2001	10
19	Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR Bioorganic & Medicinal Chemistry Letters ·Penglie Zhang, Liang Bao, Jingmei Fan, Zhaozhong J. Jia, Uma Sinha, Paul Wong, Gary Park, Athiwat Hutchaleelaha, Robert M. Scarborough, Bing‐Yan Zhu	2009	10
20	Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2V617F-Induced Murine MPD Model. Blood ·Kotaro Shide, Takuro Kameda, Vadim Markovtsov, Takuya Matsunaga, Haruko Shimoda, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Somasekhar Bhamidipati, Gary Park, Allan Torneros, Matt Duan, Yasumichi Hitoshi, Kazuya Shimoda	2009	9

About Gary Park

Gary Park is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Organic Chemistry, having authored 31 papers that have together received 880 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Vitamin K Research Studies (3 papers), Protease and Inhibitor Mechanisms (3 papers), S100 Proteins and Annexins (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (191 citations), Genetics (176 citations), Immunology (232 citations), Transplantation (14 citations) and Immunology and Allergy (29 citations). Gary Park has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Muhammad Baluom, Rajinder Singh, Elliott B. Grossbard, Vanessa Taylor, Esteban S. Masuda, Ellen Herlaar, Donald G. Payan, Sylvia Braselmann, Polly Pine and Su Wang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Transplantation, ACS Medicinal Chemistry Letters, Cancer Research and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gary Park

Impact in

Papers in i

In The Last Decade

Gary Park

Peers

Countries citing papers authored by Gary Park

Fields of papers citing papers by Gary Park

All Works

About Gary Park

Explore authors with similar magnitude of impact

Papers in